Announcements

Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica

Date of occurrence of the event: Feb 13, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …

OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare Conference

1.Date of the event: Jan 10, 2019 2.Time: 01:00:00 NST 3.Location: Westin St. Francis Hotel, San Francisco, California 4.Summary: OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare …

Company Chairman Mr. Michael N. Chang not guilty for the prosecution by Taiwan Shilin District Court

Parties to the legal matter: OBI Chairman Dr. Michael N. Chang Name of the court or disposing agency: Taiwan Shilin District Court Reference/case numbers of relevant documents: Year 106, Zhu …

OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta

1.Date of the event: Dec 20, 20182.Time: 15:00:00 NST3.Location: The Westin Taipei4.Summary: OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta 5.Any other matters that need to be …

OBI Pharma Inc. to attend the Citi’s 2018 Global Healthcare Conference

1.Date of the event: Dec 5 ~ Dec 6, 2018 2.Time: 22:00:00 NST 3.Location: The Lotte New York Palace 4.Summary: OBI Pharma Inc. to attend the Citi’s Adhd Drugs Healthcare …

Announcement of the resolution of the board of directors of the company to issue common shares through rights offering

Date of the board of directors resolution: Nov 30, 2018 Source of capital increase funds: issue common shares through rights offering Number of shares issued: 15,000,000 common shares Par value …

OBI Pharma Inc. to attend the 2018 Asia Pacific Healthcare Forum, hosted by Goldman Sachs

1.Date of the event: Nov 27 ~ Nov 28, 2018 2.Time: 09:00:00 CST 3.Location: Jw Marriott Hotel Hong Kong Level 3 Ballroom 4.Summary: OBI Pharma Inc. to attend the 2018 …

Clarification on the news article by Up Media and other media groups

Date of occurrence of the event: Nov 23, 2018 Company name: OBI Pharma Inc./ AP Biosciences Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office/subsidiary Reciprocal …

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

Date of occurrence of the event: Nov 21, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …

Department of Health (DOH) clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study in Hong Kong

Date of occurrence of the event: Nov 15, 2018 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …